JP Stock MarketDetailed Quotes

4502 Takeda Pharmaceutical

Watchlist
  • 4069.0
  • +21.0+0.52%
20min DelayMarket Closed Aug 9 15:00 JST
6.47TMarket Cap44.64P/E (Static)

Takeda Pharmaceutical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
Total revenue
14.11%1.21T
5.87%4.26T
9.91%1.05T
1.33%1.11T
4.07%1.04T
8.86%1.06T
12.85%4.03T
9.49%956.16B
21.66%1.1T
18.64%1T
Operating revenue
14.11%1.21T
5.87%4.26T
9.91%1.05T
1.33%1.11T
4.07%1.04T
8.86%1.06T
12.85%4.03T
9.49%956.16B
21.66%1.1T
18.64%1T
Cost of revenue
20.50%386.95B
14.68%1.43T
23.48%382.5B
12.95%379.48B
12.49%343.58B
9.64%321.11B
12.40%1.24T
0.45%309.77B
19.39%335.97B
10.75%305.45B
Gross profit
11.33%821.04B
1.93%2.84T
3.40%668.37B
-3.80%731.71B
0.38%699.51B
8.52%737.5B
13.05%2.78T
14.42%646.38B
22.70%760.58B
22.47%696.86B
Operating expense
15.08%654.71B
12.92%2.53T
15.85%582.61B
8.43%665.29B
26.40%748.85B
7.54%568.93B
15.55%2.24T
0.17%502.91B
21.89%613.59B
25.62%592.43B
Selling and administrative expenses
8.83%270.03B
5.67%1.05T
11.95%285.23B
1.99%267.52B
1.70%252.95B
7.19%248.11B
12.52%997.31B
14.04%254.8B
13.51%262.3B
17.32%248.73B
Research and development costs
3.52%168.46B
15.25%729.92B
21.69%195.86B
7.30%187.38B
19.33%183.95B
13.32%162.74B
20.38%633.33B
12.06%160.94B
36.03%174.63B
17.13%154.15B
Depreciation amortization depletion
25.81%162.83B
20.22%652.12B
8.92%145.11B
1.30%137.34B
68.75%240.24B
-1.41%129.42B
14.70%542.44B
-10.76%133.22B
14.81%135.58B
38.59%142.37B
-Depreciation and amortization
25.81%162.83B
20.22%652.12B
8.92%145.11B
1.30%137.34B
68.75%240.24B
-1.41%129.42B
14.70%542.44B
-10.76%133.22B
14.81%135.58B
38.59%142.37B
Other operating expenses
86.29%53.38B
40.70%91.32B
5.35%-43.59B
77.81%73.05B
51.99%71.71B
26.22%28.66B
26.09%64.91B
-222.36%-46.06B
58.86%41.08B
86.76%47.18B
Operating profit
-1.33%166.33B
-43.18%309.9B
-40.23%85.76B
-54.82%66.42B
-147.25%-49.34B
12.00%168.57B
3.83%545.42B
128.26%143.48B
26.19%146.99B
7.20%104.44B
Net non-operating interest income /expenses
12.40%-29.01B
-13.84%-140.46B
73.14%-13.9B
-17.62%-44.78B
-24.71%-48.66B
-707.04%-33.12B
0.07%-123.39B
-126.11%-51.75B
10.55%-38.07B
-18.92%-39.02B
Non-operating interest income
15.96%30.68B
105.03%11.29B
29.85%-34.81B
-47.72%21.79B
-36.69%9.36B
-56.58%26.46B
19.97%5.51B
-29.37%-49.62B
905.52%41.68B
115.36%14.78B
Non-operating interest expense
0.19%59.69B
2.19%119.54B
-442.57%-53.13B
-16.53%66.57B
7.84%58.02B
7.40%59.58B
-4.46%116.97B
53.61%-9.79B
70.75%79.75B
35.61%53.8B
Total other finance cost
----
170.31%32.22B
----
----
----
----
111.50%11.92B
----
----
----
Other net income /expenses
-70.33%-712M
-148.47%-116.65B
-172.47%-119.38B
2,342.44%39.62B
333.03%2.03B
15.90%-418M
52.71%-46.95B
53.40%-43.81B
-2.14%-1.77B
72.57%-869M
Gain on sale of security
----
-241.82%-9.13B
----
----
----
----
126.60%6.44B
----
----
----
Special income /charges
----
-69.69%-113.99B
----
----
----
----
1.47%-67.17B
----
----
----
-Less:Restructuring and mergern&acquisition
----
61.51%102.12B
----
----
----
----
-12.96%63.23B
----
----
----
-Less:Other special charges
----
122.71%18.16B
----
----
----
----
120.50%8.15B
----
----
----
-Less:Write off
----
-64.10%1.69B
----
----
----
----
--4.69B
----
----
----
-Gain on sale of business
----
15.04%7.83B
----
----
----
----
-2.98%6.81B
----
----
----
-Gain on sale of property,plant,equipment
----
-93.12%144M
----
----
----
----
82.40%2.09B
----
----
----
Income before tax
1.16%136.6B
-85.93%52.79B
-199.18%-47.52B
-42.83%61.26B
-248.69%-95.98B
-13.15%135.03B
23.97%375.09B
188.65%47.92B
48.43%107.15B
5.05%64.55B
Income tax
-9.47%41.3B
-257.46%-91.41B
-365.38%-44.53B
-270.92%-44.5B
-1,804.26%-48.01B
-9.56%45.63B
-19.82%58.05B
139.32%16.78B
-183.46%-12B
-81.77%2.82B
Net income
6.59%95.3B
-54.52%144.2B
-109.62%-2.99B
-11.24%105.76B
-177.71%-47.97B
-14.87%89.41B
37.74%317.04B
373.71%31.14B
106.07%119.15B
34.22%61.73B
Net income continuous operations
6.59%95.3B
-54.52%144.2B
-109.62%-2.99B
-11.24%105.76B
-177.71%-47.97B
-14.87%89.41B
37.74%317.04B
373.72%31.14B
106.07%119.15B
34.21%61.73B
Noncontrolling interests
363.64%51M
519.05%130M
1,100.00%24M
59.09%35M
690.00%59M
57.14%11M
-80.37%21M
111.76%2M
-56.86%22M
-132.26%-10M
Net income attributable to the company
6.55%95.25B
-54.56%144.07B
-109.69%-3.02B
-11.25%105.72B
-177.79%-48.03B
-14.87%89.4B
37.80%317.02B
374.12%31.13B
106.21%119.13B
34.33%61.74B
Net income attributable to common stockholders
6.55%95.25B
-54.56%144.07B
-109.69%-3.02B
-11.25%105.72B
-177.79%-48.03B
-14.87%89.4B
37.80%317.02B
374.12%31.13B
106.21%119.13B
34.33%61.74B
Diluted earnings per share
5.56%60.71
-54.92%92.09
-110.07%-2.01
-11.80%67.59
-177.14%-30.68
-15.35%57.51
38.84%204.29
387.34%19.97
107.61%76.63
36.01%39.77
Basic earnings per share
4.94%59.94
-54.86%91.16
-110.42%-2.01
-11.84%66.88
-177.71%-30.68
-15.45%57.12
38.44%201.94
369.41%19.29
106.82%75.86
35.76%39.48
Dividend per share
--0
4.44%188
4.44%94
--0
4.44%94
--0
0.00%180
0.00%90
--0
0.00%90
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022
Total revenue 14.11%1.21T5.87%4.26T9.91%1.05T1.33%1.11T4.07%1.04T8.86%1.06T12.85%4.03T9.49%956.16B21.66%1.1T18.64%1T
Operating revenue 14.11%1.21T5.87%4.26T9.91%1.05T1.33%1.11T4.07%1.04T8.86%1.06T12.85%4.03T9.49%956.16B21.66%1.1T18.64%1T
Cost of revenue 20.50%386.95B14.68%1.43T23.48%382.5B12.95%379.48B12.49%343.58B9.64%321.11B12.40%1.24T0.45%309.77B19.39%335.97B10.75%305.45B
Gross profit 11.33%821.04B1.93%2.84T3.40%668.37B-3.80%731.71B0.38%699.51B8.52%737.5B13.05%2.78T14.42%646.38B22.70%760.58B22.47%696.86B
Operating expense 15.08%654.71B12.92%2.53T15.85%582.61B8.43%665.29B26.40%748.85B7.54%568.93B15.55%2.24T0.17%502.91B21.89%613.59B25.62%592.43B
Selling and administrative expenses 8.83%270.03B5.67%1.05T11.95%285.23B1.99%267.52B1.70%252.95B7.19%248.11B12.52%997.31B14.04%254.8B13.51%262.3B17.32%248.73B
Research and development costs 3.52%168.46B15.25%729.92B21.69%195.86B7.30%187.38B19.33%183.95B13.32%162.74B20.38%633.33B12.06%160.94B36.03%174.63B17.13%154.15B
Depreciation amortization depletion 25.81%162.83B20.22%652.12B8.92%145.11B1.30%137.34B68.75%240.24B-1.41%129.42B14.70%542.44B-10.76%133.22B14.81%135.58B38.59%142.37B
-Depreciation and amortization 25.81%162.83B20.22%652.12B8.92%145.11B1.30%137.34B68.75%240.24B-1.41%129.42B14.70%542.44B-10.76%133.22B14.81%135.58B38.59%142.37B
Other operating expenses 86.29%53.38B40.70%91.32B5.35%-43.59B77.81%73.05B51.99%71.71B26.22%28.66B26.09%64.91B-222.36%-46.06B58.86%41.08B86.76%47.18B
Operating profit -1.33%166.33B-43.18%309.9B-40.23%85.76B-54.82%66.42B-147.25%-49.34B12.00%168.57B3.83%545.42B128.26%143.48B26.19%146.99B7.20%104.44B
Net non-operating interest income /expenses 12.40%-29.01B-13.84%-140.46B73.14%-13.9B-17.62%-44.78B-24.71%-48.66B-707.04%-33.12B0.07%-123.39B-126.11%-51.75B10.55%-38.07B-18.92%-39.02B
Non-operating interest income 15.96%30.68B105.03%11.29B29.85%-34.81B-47.72%21.79B-36.69%9.36B-56.58%26.46B19.97%5.51B-29.37%-49.62B905.52%41.68B115.36%14.78B
Non-operating interest expense 0.19%59.69B2.19%119.54B-442.57%-53.13B-16.53%66.57B7.84%58.02B7.40%59.58B-4.46%116.97B53.61%-9.79B70.75%79.75B35.61%53.8B
Total other finance cost ----170.31%32.22B----------------111.50%11.92B------------
Other net income /expenses -70.33%-712M-148.47%-116.65B-172.47%-119.38B2,342.44%39.62B333.03%2.03B15.90%-418M52.71%-46.95B53.40%-43.81B-2.14%-1.77B72.57%-869M
Gain on sale of security -----241.82%-9.13B----------------126.60%6.44B------------
Special income /charges -----69.69%-113.99B----------------1.47%-67.17B------------
-Less:Restructuring and mergern&acquisition ----61.51%102.12B-----------------12.96%63.23B------------
-Less:Other special charges ----122.71%18.16B----------------120.50%8.15B------------
-Less:Write off -----64.10%1.69B------------------4.69B------------
-Gain on sale of business ----15.04%7.83B-----------------2.98%6.81B------------
-Gain on sale of property,plant,equipment -----93.12%144M----------------82.40%2.09B------------
Income before tax 1.16%136.6B-85.93%52.79B-199.18%-47.52B-42.83%61.26B-248.69%-95.98B-13.15%135.03B23.97%375.09B188.65%47.92B48.43%107.15B5.05%64.55B
Income tax -9.47%41.3B-257.46%-91.41B-365.38%-44.53B-270.92%-44.5B-1,804.26%-48.01B-9.56%45.63B-19.82%58.05B139.32%16.78B-183.46%-12B-81.77%2.82B
Net income 6.59%95.3B-54.52%144.2B-109.62%-2.99B-11.24%105.76B-177.71%-47.97B-14.87%89.41B37.74%317.04B373.71%31.14B106.07%119.15B34.22%61.73B
Net income continuous operations 6.59%95.3B-54.52%144.2B-109.62%-2.99B-11.24%105.76B-177.71%-47.97B-14.87%89.41B37.74%317.04B373.72%31.14B106.07%119.15B34.21%61.73B
Noncontrolling interests 363.64%51M519.05%130M1,100.00%24M59.09%35M690.00%59M57.14%11M-80.37%21M111.76%2M-56.86%22M-132.26%-10M
Net income attributable to the company 6.55%95.25B-54.56%144.07B-109.69%-3.02B-11.25%105.72B-177.79%-48.03B-14.87%89.4B37.80%317.02B374.12%31.13B106.21%119.13B34.33%61.74B
Net income attributable to common stockholders 6.55%95.25B-54.56%144.07B-109.69%-3.02B-11.25%105.72B-177.79%-48.03B-14.87%89.4B37.80%317.02B374.12%31.13B106.21%119.13B34.33%61.74B
Diluted earnings per share 5.56%60.71-54.92%92.09-110.07%-2.01-11.80%67.59-177.14%-30.68-15.35%57.5138.84%204.29387.34%19.97107.61%76.6336.01%39.77
Basic earnings per share 4.94%59.94-54.86%91.16-110.42%-2.01-11.84%66.88-177.71%-30.68-15.45%57.1238.44%201.94369.41%19.29106.82%75.8635.76%39.48
Dividend per share --04.44%1884.44%94--04.44%94--00.00%1800.00%90--00.00%90
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
% Chg